| Schedule of Changes In Consolidated Equity |
The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Treasury Stock | | Noncontrolling Interests | | Total Equity | | | | | | | Shares Outstanding | | Issued Par Amount | | | | | | | | | | | | Balances at December 31, 2025 | | 86,952 | | | $ | 8 | | | $ | 4,914 | | | $ | (181) | | | $ | 4,415 | | | $ | (4,936) | | | $ | 1,797 | | | $ | 6,017 | | | | | | | Net income | | — | | | — | | | — | | | — | | | 702 | | | — | | | 93 | | | 795 | | | | | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (75) | | | (75) | | | | | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Purchases of businesses and noncontrolling interests, net | | — | | | — | | | 270 | | | — | | | — | | | — | | | 84 | | | 354 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Repurchases of common stock | | (1,346) | | | — | | | — | | | — | | | — | | | (320) | | | — | | | (320) | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 518 | | | — | | | (60) | | | — | | | — | | | — | | | — | | | (60) | | | | | | | Balances at March 31, 2026 | | 86,124 | | | 8 | | | 5,124 | | | (179) | | | 5,117 | | | (5,256) | | | 1,899 | | | 6,713 | | | | | | | Net income | | — | | | — | | | — | | | — | | | 826 | | | — | | | 106 | | | 932 | | | | | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (78) | | | (78) | | | | | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Purchases (sales) of businesses and noncontrolling interests, net | | — | | | — | | | 22 | | | — | | | — | | | — | | | (28) | | | (6) | | | | | | | Repurchases of common stock | | (5,675) | | | — | | | — | | | — | | | — | | | (1,052) | | | — | | | (1,052) | | | | | | | | | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 58 | | | — | | | 46 | | | — | | | — | | | — | | | — | | | 46 | | | | | | | Balances at June 30, 2026 | | 80,507 | | | $ | 8 | | | $ | 5,192 | | | $ | (177) | | | $ | 5,943 | | | $ | (6,308) | | | $ | 1,899 | | | $ | 6,557 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Treasury Stock | | Noncontrolling Interests | | Total Equity | | | Shares Outstanding | | Issued Par Amount | | | | | | | | Balances at December 31, 2024 | | 95,109 | | | $ | 8 | | | $ | 4,873 | | | $ | (180) | | | $ | 3,008 | | | $ | (3,538) | | | $ | 1,649 | | | $ | 5,820 | | | Net income | | — | | | — | | | — | | | — | | | 406 | | | — | | | 95 | | | 501 | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (89) | | | (89) | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | Purchases (sales) of businesses and noncontrolling interests, net | | — | | | — | | | (35) | | | — | | | — | | | — | | | 41 | | | 6 | | | Repurchases of common stock | | (2,629) | | | — | | | — | | | — | | | — | | | (351) | | | — | | | (351) | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 405 | | | — | | | (12) | | | — | | | — | | | — | | | — | | | (12) | | | Balances at March 31, 2025 | | 92,885 | | | 8 | | | 4,826 | | | (178) | | | 3,414 | | | (3,889) | | | 1,696 | | | 5,877 | | | Net income | | — | | | — | | | — | | | — | | | 288 | | | — | | | 105 | | | 393 | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (83) | | | (83) | | | Other comprehensive income | | — | | | — | | | — | | | 1 | | | — | | | — | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | Purchases of businesses and noncontrolling interests, net | | — | | | — | | | 10 | | | — | | | — | | | — | | | 9 | | | 19 | | | Repurchases of common stock | | (4,601) | | | — | | | — | | | — | | | — | | | (753) | | | — | | | (753) | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 60 | | | — | | | 22 | | | — | | | — | | | — | | | — | | | 22 | | | Balances at June 30, 2025 | | 88,344 | | | $ | 8 | | | $ | 4,858 | | | $ | (177) | | | $ | 3,702 | | | $ | (4,642) | | | $ | 1,727 | | | $ | 5,476 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Changes in Redeemable Noncontrolling Interests in Equity of Consolidated Subsidiaries |
The table below presents our nonredeemable noncontrolling interests balances by segment: | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Hospital Operations | | $ | 214 | | | $ | 211 | | | Ambulatory Care | | 1,685 | | | 1,586 | | | Total nonredeemable noncontrolling interests | | $ | 1,899 | | | $ | 1,797 | |
The table below presents our net income available to nonredeemable noncontrolling interests by segment: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | Hospital Operations | | $ | 9 | | | $ | 12 | | | $ | 19 | | | $ | 24 | | | Ambulatory Care | | 97 | | | 93 | | | 180 | | | 176 | | | Total net income available to nonredeemable noncontrolling interests | | $ | 106 | | | $ | 105 | | | $ | 199 | | | $ | 200 | |
|
| Schedule of Share Repurchase Activity |
The table below presents repurchase activity under our share repurchase program: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Period | | | | Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Program | | Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program | | | | | | | (In Thousands) | | | | (In Thousands) | | (In Millions) | | | January 1 through June 30, 2026 | | | | | | | | | | | | | January 1 through January 31, 2026 | | | | — | | $ | — | | | — | | $ | 1,490 | | | | February 1 through February 28, 2026 | | | | — | | $ | — | | | — | | $ | 1,490 | | | | March 1 through March 31, 2026 | | | | 1,346 | | $ | 236.30 | | | 1,346 | | $ | 1,172 | | | | April 1 through April 30, 2026 | | | | — | | $ | — | | | — | | $ | 1,172 | | | | May 1 through May 31, 2026 | | | | 4,031 | | $ | 190.26 | | | 4,031 | | $ | 405 | | | | June 1 through June 30, 2026 | | | | 1,644 | | $ | 167.20 | | | 1,644 | | $ | 2,130 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | January 1 through June 30, 2025 | | | | | | | | | | | | | January 1 through January 31, 2025 | | | | — | | $ | — | | | — | | $ | 1,376 | | | | February 1 through February 28, 2025 | | | | 1,800 | | $ | 134.98 | | | 1,800 | | $ | 1,133 | | | | March 1 through March 31, 2025 | | | | 829 | | $ | 126.67 | | | 829 | | $ | 1,028 | | | | April 1 through April 30, 2025 | | | | — | | $ | — | | | — | | $ | 1,028 | | | | May 1 through May 31, 2025 | | | | 2,456 | | $ | 157.57 | | | 2,456 | | $ | 641 | | | | June 1 through June 30, 2025 | | | | 2,145 | | $ | 167.83 | | | 2,145 | | $ | 281 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|